Ashfield Meetings & Events, part of UDG Healthcare, will be presenting the findings of its latest white paper, The Science Of Healthcare Professional Meetings, at this year’s International Pharmaceutical Congress Advisory Association (IPCAA) Annual Seminar on Compliance in Berlin, 20-21 March.
As a follow on from the international healthcare events specialist’s 2016 study – The Future of Meetings – Andrew Moore, Ashfield’s head of technology & compliance, and client relationship director, Lee-Anne Penn will compare and contrast the perceptions of healthcare professionals (HCPs) across a wide variety of speciality areas, diving deeper into the ongoing evolution of the medical meetings landscape.
“We’ve looked at the individual component factors of why HCPs attend events to better understand their motivations and desires,” said Moore. “This has helped us really define a strategy for successful meetings in the future.”
Moore continued: “It was encouraging to discover that HCPs are saying their ‘preferred channel’ for receiving scientific content is through attendance at a scientific congress or meeting, but it was also important to explore any barriers they felt might be impacting their ability to attend – including regulatory barriers.”
Moore and Penn will also highlight the white paper’s conclusions around the impact of Transfer of Value disclosure, the importance of a return on the time and money invested in attending, and the value and effect real-life experiences from patients have in HCPs’ learning.
“Collating the data for the Science Of Meetings has been invaluable,” added Penn. “Its findings will not only help healthcare companies deliver insight-led, personalised HCP experiences that guarantee both engagement and impact, but it will also reassure HCPs that they are being listened to as events evolve to meet their needs.”
